The Hantavirus Scare Brought 3 Covid-Era Stocks Back in the Spotlight

The hantavirus outbreak on the MV Hondius lifted one mRNA leader 36% off May lows before profit-taking trimmed the rally. The brief move reactivated the pandemic-prep trade across medical stocks, putting three Covid-era stocks back on the 2026 comeback watchlist. Each setup carries a different signal. One name has already moved on to the mRNA